Kozak & Associates, Inc. United Therapeutics Corp Transaction History
Kozak & Associates, Inc.
- $397 Million
- Q2 2024
A detailed history of Kozak & Associates, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Kozak & Associates, Inc. holds 21 shares of UTHR stock, worth $7,525. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21
Previous 21
-0.0%
Holding current value
$7,525
Previous $4,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding UTHR
# of Institutions
619Shares Held
45MCall Options Held
368KPut Options Held
410K-
Black Rock Inc. New York, NY5.47MShares$1.96 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.42MShares$1.58 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.29MShares$1.18 Billion0.19% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.02 Billion12.43% of portfolio
-
State Street Corp Boston, MA2.29MShares$822 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.3B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...